The rate of
nucleoside transport decreased profoundly in human promyelocytic
leukemia HL-60 cells after myeloid differentiation was induced by 5-6 days of exposure to 0.8%
N,N-dimethylformamide (DMF). The facilitated diffusion of 100 microM radiolabeled
adenosine and
2'-deoxyadenosine, measured by rapid transport assays, decreased 10- to 20-fold. The transport of 2 microM
coformycin or
2'-deoxycoformycin, which is mediated by the same mechanism and was monitored by the
adenosine deaminase titration assay, decreased 29-fold. The reduction in
nucleoside transport capacity after DMF treatment was confirmed by a 19-fold decrease in the number of specific binding sites per cell (from 24-30 X 10(4) to 1.2-1.7 X 10(4)) for [3H]-6-p-nitrobenzylthioinosine, a
nucleoside transport inhibitor. The binding affinity of 6-p-nitrobenzylthioinosine was not altered significantly and
nucleoside transport remained sensitive to the transport inhibitors, 6-p-nitrobenzylthioinosine,
dipyridamole, and
dilazep after DMF-induced maturation. Time-dependence studies showed that the rate of 100 microM
deoxyadenosine transport was unchanged for the first 24 h of exposure to DMF but fell to about 36% of control rates at 24-26 h and then gradually decreased further to about 4-5% of control rates after 5-6 days. In contrast, transport rates of the
purine bases were reduced only 2- to 3-fold in HL-60 cells after 5 days of DMF treatment. The rates of
adenosine and
deoxyadenosine transport were unchanged or reduced by no more than 2-fold after 5-6 days of exposure to 0.8% DMF in the following human tumor cell lines that are not inducible with DMF: ARH-77 (
multiple myeloma), KG-1 (acute myelogenous), and K-562 (chronic myelogenous). Thus, changes in
nucleoside transport may serve as an early, membrane-associated marker of differentiation of the HL-60 cell line.